Global Gene Therapy for Blood Disorders Market Assessment 2020 - Key Player such as Biomarin Therapeutics, Spark Therapeutics, Shire, bluebird bio, Inc., CRISPR Therapeutics, Medgenics, OrphageniX and many more.
Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-gene-therapy-for-blood-disorders-market-assessment/
According to the latest research by InsightAce Analytic, the global market for gene therapy for blood disorders is estimated to be valued at US$ XX million in 2020 and is expected to reach US$ XX million by 2030, with a remarkable CAGR of XX% from 2020 to 2030.
Gene therapy represents a new approach in human health with the potential to resolve unmet medical needs by using genes to cure, treat, or prevent disease. It fixes defective or mutated genes that require either correction or improved regulation by injecting properly functioning genes into the cells of a patient.
Gene therapy mainly target diseases such as cystic fibrosis, hemophilia, muscular dystrophy, thalassemia, and sickle-cell anemia, as well as a plethora of other monogenic diseases.
Additionally, a substantial amount of gene therapy research and clinical development is also being conducted for cardiovascular disease, neurological disease, and ocular disease, many of which are classified as regenerative gene therapies.
The significant number of ongoing clinical trials related to gene therapy to treat several disorders, strong product pipeline, enhanced research activities by the players, significant prevalence of blood disorders and growing demand for gene therapy to treat blood disorders which have inadequate treatment options are the major growth drivers of the global gene therapy market. For instance, as of November 2020, as per ClinicalTrials.gov, over 3000 human gene therapy interventional clinical trials have been reported globally.
Gene therapy is expected to unite market leaders in the blood disorders treatment arena to research and overcome the commercial challenges and hurdles faced by them while developing gene therapies for sickle cell disease, hemophilia, and β-thalassemia. For instance, in 2018 Sanofi Genzyme, acquired Bioverativ and Ablynx to strengthen its position and offering in the rare blood disorders space.
In January 2020, Sangamo Therapeutics handed over a development of gene therapy, SB-525 to Pfizer for hemophilia A. The candidate is currently under phase 3 of clinical development. The introduction of pipeline drugs to the market in the coming years is expected to generate potential opportunities for the growth of the market during the estimated timeframe.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-gene-therapy-for-blood-disorders-market-assessment/
Global gene therapy for blood disorders market report covers prominent players such as Biomarin Therapeutics, Spark Therapeutics, Shire, bluebird bio, Inc., CRISPR Therapeutics, Medgenics, OrphageniX, Freeline Therapeutics, Errant Gene Therapeutics, Sangamo Therapeutics, Sigilon Therapeutics, Inc., uniQure, Angiocrine Bioscience, and Sanofi Genzyme.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-gene-therapy-for-blood-disorders-market-assessment/
Global Gene Therapy for Blood Disorders Market Revenue (US$ Mn), By Indication, 2020-2030
o Sickle Cell Anemia
o Hemophilia B
o Hemophilia A
Global Gene Therapy for Blood Disorders Market Revenue (US$ Mn), By Mechanism of Action, 2020-2030
o Gene Therapy
o Gene Editing
Global Gene Therapy for Blood Disorders Market Revenue (US$ Mn), By Region, 2020-2030
North America Gene Therapy for Blood Disorders Market Revenue (US$ Mn), By Country, 2020-2030
Europe Gene Therapy for Blood Disorders Market Revenue (US$ Mn), By Country, 2020-2030
o Rest of Europe
Asia Pacific Gene Therapy for Blood Disorders Market Revenue (US$ Mn), 2020-2030
Latin America Gene Therapy for Blood Disorders Market Revenue (US$ Mn), 2020-2030
Middle East & Africa Gene Therapy for Blood Disorders Market Revenue (US$ Mn), 2020-2030
Why should buy this report:
To receive a comprehensive analysis of the growth prospects for the global gene therapy for blood disorders market
To receive industry overview and future trends in the gene therapy for blood disorders market
To analyze the major factors (drivers and restraints) influencing the growth of the gene therapy for blood disorders market
To get information on the gene therapy for blood disorders market size value/revenue (US$ Mn) forecast till 2028
To analyze the competitive developments such as major investments, mergers & acquisition in the gene therapy for blood disorders industry
For More Information @ https://www.insightaceanalytic.com/report-details/global-gene-therapy-for-blood-disorders-market-assessment/
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gene Therapy for Blood Disorders Market Assessment 2020 - Key Player such as Biomarin Therapeutics, Spark Therapeutics, Shire, bluebird bio, Inc., CRISPR Therapeutics, Medgenics, OrphageniX and many more. here
News-ID: 2191530 • Views: 523
More Releases from InsightAce Analytic Pvt. Ltd.
Global Oncolytic Virus Therapy Market | Provectus Biopharmaceuticals, Inc. , Tak …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "global oncolytic virus therapy market trends, industry competition analysis, revenue and forecast to 2030." Request for Sample Pages: https://www.insightaceanalytic.com/report/global-oncolytic-virus-therapy-market/1087 Oncolytic virus therapy is a type of cancer therapy that uses viruses to infect and destroy malignant cells and activate the patient’s immune system to recognize the cancer cells as “foreign tissue.” Such novel treatments are desperately needed to
Global Artificial Intelligence in Genomics Market | AI Therapeutics , Inc., Ares …
InsightAce Analytic Pvt. Ltd. is pleased to announce the publication of a market analysis research on the "global artificial intelligence in genomics market trends, industry competition analysis, revenue and forecast to 2030." Request for Sample Pages: https://www.insightaceanalytic.com/report/global-artificial-intelligence-in-genomics-market/1122 Artificial intelligence plays a vital role in genomics to develop and innovate effective drugs and treatments for curing various diseases. It also enhances the interpretability of genomic data and improves the efficacy of the overall
Global Next-Generation Personalized Nutrition Market | Arborvitae, Baze, Biogeni …
InsightAce Analytic Pvt. Ltd. is pleased to announce the publication of a market analysis research on “Global Next-Generation Personalized Nutrition Market Assessment – Revenue (US$ Mn) Forecast Till 2028.” Request for Sample Pages: https://www.insightaceanalytic.com/report/global-next-generation-personalized-nutrition-market/1047 Personalized nutrition has been increasingly apparent in recent years, with the assessment of dietary patterns providing a more dependable and disciplined approach to enhancing health. A customized nutrition technique is based on tailoring nutrition recommendations or making
Global Personalized Skin Care Market |Atolla, Ave & Edam, Clinique Laboratories, …
InsightAce Analytic Pvt. Ltd. is pleased to announce the publication of a market analysis research on "Global Personalized Skin Care Market Assessment-Industry Analysis, Competitive Analysis And Revenue Forecast Till 2028." Request for Sample Pages: https://www.insightaceanalytic.com/report/global-personalized-skin-care-market-/1165 Now a day, beauty and grooming are part of the daily skincare routine. Beauty buyers are always in search of clean, vegan, safe, and high-quality products. So, here emerges a new trend of personalized skincare. Next-Generation customized
More Releases for Gene
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Editing Technologies Market
Gene editing with engineered nucleases is anticipated to contribute significantly to the global life sciences industry. Gene editing provides application from studying gene functions in plants and animals to gene therapy in humans. Gene editing has more efficiency than many other methods in reverse genetics. Increased development of genetic engineering and increased funding in the field of gene editing is anticipated to drive the growth of the global gene editing